THE APPLICATION OF HUMAN COMPLEMENT FACTOR H-RELATED PROTEIN (BTA TRAK) IN MONITORING PATIENTS WITH BLADDER CANCER
- 1 February 2000
- journal article
- review article
- Published by Elsevier in Urologic Clinics of North America
- Vol. 27 (1) , 63-73
- https://doi.org/10.1016/s0094-0143(05)70235-4
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- THE RELATIONSHIP BETWEEN SERIAL MEASUREMENTS OF THE LEVEL OF A BLADDER TUMOR ASSOCIATED ANTIGEN AND THE POTENTIAL FOR RECURRENCEJournal of Urology, 1999
- RAPID PROTECTION OF BLADDER CANCER: A COMPARATIVE STUDY OF POINT OF CARE TESTSJournal of Urology, 1997
- Significance of the BTA Test in Bladder Cancer: A Multicenter TrialInternational Journal of Urology, 1997
- A Multicenter Trial Evaluation of the Fibrin/Fibrinogen Degradation Products Test for Detection and Monitoring of Bladder CancerJournal of Urology, 1997
- The use of the bladder-tumour associated analyte test to determine the type of cystoscopy in the follow-up of patients with bladder cancerBJU International, 1997
- Use of a New Tumor Marker, Urinary NMP22, in the Detection of Occult or Rapidly Recurring Transitional Cell Carcinoma of the Urinary Tract Following Surgical TreatmentJournal of Urology, 1996
- Initial Evaluation of the Bladder Tumor Antigen Test in Superficial Bladder CancerJournal of Urology, 1996
- Results of a Multicenter Trial using the BTA Test to Monitor for and Diagnose Recurrent Bladder CancerJournal of Urology, 1995
- Human complement factor H: two factor H proteins are derived from alternatively spliced transcriptsEuropean Journal of Immunology, 1991
- Basic principles of ROC analysisSeminars in Nuclear Medicine, 1978